BackFennec Pharmaceuticals Overview

Fennec Pharmaceuticals Receivables

Track Fennec Pharmaceuticals's receivables ($23M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$23.27M
32.93% YoYΔ $5.76M vs prior year quarter

Peer trimmed avg / median

Loading

Fennec Pharmaceuticals Receivables History

Loading

Fennec Pharmaceuticals vs. peers: Receivables Comparison

Loading

Fennec Pharmaceuticals Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Fennec Pharmaceuticals (FENC) FAQ

As of the most recent data (June 2026), FENC shows a receivables of $23M. That compares with $18M in the prior-year period — up 32.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, FENC's receivables is now $23M (was $18M) — a 32.9% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Fennec Pharmaceuticals is outperforming or lagging.

Tracking FENC's receivables over time shows whether Fennec Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $23M That compares with $18M in the prior-year period — up 32.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Fennec Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $23M) with ownership activity and broader fundamentals.

Fennec Pharmaceuticals's receivables is $23M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.